Results 111 to 120 of about 938,592 (268)

Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90.

open access: yesPLoS Pathogens, 2014
Antibodies targeting receptor-mediated entry of HCV into hepatocytes confer limited therapeutic benefits. Evidence suggests that exosomes can transfer genetic materials between cells; however, their role in HCV infection remains obscure.
Terence N Bukong   +4 more
doaj   +1 more source

Sociodemographic characteristics of the hepatitis C virus (HCV) infected subjects stratified by the HCV-RNA status.

open access: yes, 2018
Sociodemographic characteristics of the hepatitis C virus (HCV) infected subjects stratified by the HCV-RNA status.
Giancarlo Di Giuseppe (6078743)   +2 more
core   +1 more source

Changes in cardiometabolic biomarkers 1 year after direct acting antiviral therapy for hepatitis C virus co‐infection among people with HIV

open access: yesHIV Medicine, EarlyView.
Abstract Objectives Among people with HIV with hepatitis C virus (HCV) co‐infection, we examined differences in haemoglobin A1c (HbA1c), total cholesterol (TC), low‐density lipoprotein (LDL), high‐density lipoprotein (HDL) and atherosclerotic cardiovascular disease (ASCVD) risk score at 12‐months following direct acting antiviral (DAA) initiation ...
Raynell Lang   +16 more
wiley   +1 more source

COMPARISON OF HCV RNA AND HCV CORE ANTIGEN IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS [PDF]

open access: yes, 2014
Ankarali, Handan Camdeviren/0000-0002-3613-0523; Karabay, Oguz/0000-0003-0502-432XWOS: 000364114800009Background: Anti-HCV test is currently used in the diagnosis of hepatitis C, while hepatitis C virus ribonucleic acid (HCV RNA) is used in the ...
Özdemir, Fatma   +5 more
core   +2 more sources

Longitudinal changes in readily available inflammatory markers before and after switching to integrase inhibitor‐based antiretroviral therapy in Virologically suppressed people living with HIV: A Nationwide real‐world cohort study

open access: yesHIV Medicine, EarlyView.
Abstract Background Persistent immune activation and systemic inflammation remain key features of chronic HIV infection despite sustained virological suppression under antiretroviral therapy (ART), contributing to excess non‐AIDS morbidity and mortality.
Stelios F. Assimakopoulos   +71 more
wiley   +1 more source

HCV RNA and age of infection.

open access: yes, 2014
HCV RNA and age of infection.
Ashwin Balagopal (19837)   +6 more
core   +1 more source

Pregnancy and neonatal outcomes after prenatal exposure to dolutegravir: Data from a European cohort collaboration

open access: yesHIV Medicine, EarlyView.
Abstract Objective We aimed to assess ‘real‐world’ pregnancy and neonatal outcomes following prenatal dolutegravir (DTG) use in a European setting. Methods We conducted a pooled analysis of individual‐patient data from seven observational studies. Pregnancies with DTG exposure any time from the periconception period (≤6 completed gestational weeks ...
Rebecca Sconza   +22 more
wiley   +1 more source

Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.

open access: yesPLoS ONE, 2015
BackgroundUnderstanding the patterns of HCV RNA levels during acute hepatitis C virus (HCV) infection provides insights into immunopathogenesis and is important for vaccine design.
Behzad Hajarizadeh   +19 more
doaj   +1 more source

NGS of HCV biopsy RNA.

open access: yes, 2013
Extracted and pooled (×6) HCV infected biopsy RNA was reverse transcribed and amplified prior to Illumina NGS and mapped to the HCV reference 3a.NZL. NC_0009824 (Los Alamos HCV database).
Paul Kellam (6413)   +12 more
core   +1 more source

Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement

open access: yesInternal Medicine Journal, EarlyView.
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy